N03AX21 retigabine
ATC group of level 5 – chemical substance · in plain English: medicines for epilepsy
This site has the patient leaflet or the SPC of 1 medicine in this group.
Active substance: Retigabine – all medicines with this substance, also in combinations.
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N03 Antiepileptics 1,124 medicines
- N03A Antiepileptics 1,124 medicines
- N03AX Other antiepileptics 837 medicines
- N03AX21 retigabine 1 medicine
- N03AX Other antiepileptics 837 medicines
- N03A Antiepileptics 1,124 medicines
- N03 Antiepileptics 1,124 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Trobalt SPC | – |
Other groups of the same level
- N03AX03 sultiame 1 medicine
- N03AX09 lamotrigine 87 medicines
- N03AX11 topiramate 66 medicines
- N03AX12 gabapentin 70 medicines
- N03AX14 levetiracetam 160 medicines
- N03AX15 zonisamide 47 medicines
- N03AX16 pregabalin 180 medicines
- N03AX17 stiripentol 8 medicines
- N03AX18 lacosamide 101 medicines
- N03AX22 perampanel 35 medicines
- N03AX23 brivaracetam 71 medicines
- N03AX24 cannabidiol 1 medicine
- N03AX25 cenobamate 7 medicines
- N03AX26 fenfluramine 1 medicine
Other names of the ATC group
- French: N03AX21 rétigabine
- German: N03AX21 Retigabin
- Spanish: N03AX21 RETIGABINA
- German: N03AX21 Retigabin
- Italian: N03AX21 RETIGABINA
- Turkish: N03AX21 retigabin
- Portuguese (Brazil): N03AX21 Retigabina
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N03AX21
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
